Taxus Pharmaceuticals Holdings Inc logo

TXSP - Taxus Pharmaceuticals Holdings Inc Share Price

$3.35 0.0  0.0%

Last Trade - 12/06/20

Sector
Consumer Defensives
Size
Small Cap
Market Cap £207.7m
Enterprise Value £207.7m
Revenue £0.380k
Position in Universe th / 6362
Bullish
Bearish
Unlock TXSP Revenue
Momentum
Relative Strength (%)
1m +1.02%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.14 0.15 0.10 0.061 0.006 -54.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 March 2018, Taxus Pharmaceuticals Holdings Inc revenues decreased 91% to $1K. Net loss decreased 78% to $19K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Selling/General/Admin. Expense decrease of 78% to $19K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TXSP Revenue Unlock TXSP Revenue

Net Income

TXSP Net Income Unlock TXSP Revenue

Normalised EPS

TXSP Normalised EPS Unlock TXSP Revenue

PE Ratio Range

TXSP PE Ratio Range Unlock TXSP Revenue

Dividend Yield Range

TXSP Dividend Yield Range Unlock TXSP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TXSP EPS Forecasts Unlock TXSP Revenue
Profile Summary

Taxus Pharmaceuticals Holdings, Inc. is a specialty retailer. The Company sells dietary supplement products, such as vitamins, minerals, calcium, fibers and proteins, among others. The Company operates a retail store, which is located in Little Neck, New York. The Company seeks to open various retail stores in the Borough of Queens, New York City, New York.

Directors
Last Annual June 30th, 2017
Last Interim March 31st, 2018
Incorporated January 2, 2002
Public Since June 19, 2015
No. of Shareholders: 39
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange OTC Markets Group
Shares in Issue 81,500,200
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TXSP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TXSP
Upcoming Events for TXSP
Frequently Asked Questions for Taxus Pharmaceuticals Holdings Inc
What is the Taxus Pharmaceuticals Holdings Inc share price?

As of 12/06/20, shares in Taxus Pharmaceuticals Holdings Inc are trading at $3.35, giving the company a market capitalisation of £207.7m. This share price information is delayed by 15 minutes.

How has the Taxus Pharmaceuticals Holdings Inc share price performed this year?

Shares in Taxus Pharmaceuticals Holdings Inc are currently trading at $3.35 and the price has moved by 5.68% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Taxus Pharmaceuticals Holdings Inc price has moved by -3.3% over the past year.

What are the analyst and broker recommendations for Taxus Pharmaceuticals Holdings Inc?

There are no analysts currently covering Taxus Pharmaceuticals Holdings Inc.

When will Taxus Pharmaceuticals Holdings Inc next release its financial results?

Taxus Pharmaceuticals Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-03-31
What is the Taxus Pharmaceuticals Holdings Inc dividend yield?

Taxus Pharmaceuticals Holdings Inc does not currently pay a dividend.

Does Taxus Pharmaceuticals Holdings Inc pay a dividend?

Taxus Pharmaceuticals Holdings Inc does not currently pay a dividend.

When does Taxus Pharmaceuticals Holdings Inc next pay dividends?

Taxus Pharmaceuticals Holdings Inc does not currently pay a dividend.

How do I buy Taxus Pharmaceuticals Holdings Inc shares?

To buy shares in Taxus Pharmaceuticals Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Taxus Pharmaceuticals Holdings Inc?

Shares in Taxus Pharmaceuticals Holdings Inc are currently trading at $3.35, giving the company a market capitalisation of £207.7m.

Where are Taxus Pharmaceuticals Holdings Inc shares listed? Where are Taxus Pharmaceuticals Holdings Inc shares listed?

Here are the trading details for Taxus Pharmaceuticals Holdings Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: TXSP
What kind of share is Taxus Pharmaceuticals Holdings Inc?

We were not able to load our ranking data for Taxus Pharmaceuticals Holdings Inc

Is there a Taxus Pharmaceuticals Holdings Inc share price forecast 2020?

We were not able to load any forecast data for Taxus Pharmaceuticals Holdings Inc.

How can I tell whether the Taxus Pharmaceuticals Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Taxus Pharmaceuticals Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 8.14%. At the current price of $3.35, shares in Taxus Pharmaceuticals Holdings Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Taxus Pharmaceuticals Holdings Inc PE Ratio?

We were not able to find PE ratio data for Taxus Pharmaceuticals Holdings Inc.

Who are the key directors of Taxus Pharmaceuticals Holdings Inc?

Taxus Pharmaceuticals Holdings Inc's management team is headed by:

Jiayue Zhang - PRE
Who are the major shareholders of Taxus Pharmaceuticals Holdings Inc?

Here are the top five shareholders of Taxus Pharmaceuticals Holdings Inc based on the size of their shareholding:

Similar to TXSP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.